OT-404, a Small Molecule NFKB and Oxidative Stress Inhibitor Protects Against Cisplatin-Induced Peripheral Neuropathy

Text Registration

OT-404, a Small Molecule NFKB and Oxidative Stress Inhibitor Protects Against Cisplatin-Induced Peripheral Neuropathy

Status

Published

on 13 Jan 2015

Year of Creation

2014

Ryyan Alobaidi

Registration Number

TX0008061087

on 13 Jan 2015

The U.S. Copyright record (Registration Number: TX0008061087) dated 13 Jan 2015, pertains to an electronic file (eService) titled "OT-404, a Small Molecule NFKB and Oxidative Stress Inhibitor Protects Against Cisplatin-Induced Peripheral Neuropathy" created in 2014. The copyright holder is Ryyan Alobaidi, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Ryyan Alobaidi.

Ryyan Alobaidi

Application Details

Registration Number

TX0008061087

Registration Date

1/13/2015

Year of Creation

2014

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Ryyan Alobaidi

Notes

Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 x7020, disspub@email.com

Statements

Application Title Statement: OT-404, a Small Molecule NFKB and Oxidative Stress Inhibitor Protects Against Cisplatin-Induced Peripheral Neuropathy

Author Statement: Ryyan Alobaidi Citizenship: not known Authorship: text

Notes

Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 x7020, disspub@email.com

Statements

Application Title Statement: OT-404, a Small Molecule NFKB and Oxidative Stress Inhibitor Protects Against Cisplatin-Induced Peripheral Neuropathy

Author Statement: Ryyan Alobaidi Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.